+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Microbiome Diagnostics Market - Global Forecast 2026-2032- Product Image
Microbiome Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Microbiome Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5968243
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The microbiome diagnostics market is gaining momentum as emerging technologies, workflow improvements, and increased clinical focus allow laboratory discoveries to be translated into routine healthcare applications. Senior decision-makers now require insights into the evolving landscape to inform strategy, investment, and operational planning.

Market Snapshot: Microbiome Diagnostics Market Size and Growth

The microbiome diagnostics market grew from USD 1.16 billion in 2025 to USD 1.41 billion in 2026, and is projected to reach USD 4.63 billion by 2032 with a CAGR of 21.77%. This strong growth is fueled by wider clinical adoption, new application areas, and technological advancements in sequencing and bioinformatics platforms. Recognition among senior healthcare leaders is increasing, particularly regarding the role of microbiome diagnostics in early disease detection, patient stratification, and supporting value-based care. These trends set the stage for rapid market expansion and a shift toward actionable, practical solutions in clinical settings.

Scope & Segmentation

  • Technologies: Microarray platforms, next-generation sequencing (including 16S rRNA, shotgun metagenomics, whole genome sequencing), digital and real-time PCR, supported by bioinformatics suites. These methods enable both targeted diagnostics and comprehensive profiling, while assay standardization and improved analytics support scaling and reproducibility.
  • Applications: Disease diagnosis, drug development with emphasis on biomarker discovery and powering clinical trials, personalized nutrition, risk assessment, and therapeutic monitoring. These varied uses influence the choice of technologies, regulatory requirements, and workflow design, with an increasing focus on clinical relevance.
  • Sample Types: Blood, fecal, oral, skin, and urine samples drive diverse testing needs, each with unique extraction protocols and diagnostic value depending on clinical context and indication.
  • Clinical Indications: Gastrointestinal and dermatological disorders, infectious diseases, metabolic conditions, and oncology. Each indication involves tailored analytical approaches and distinct evidence pathways to ensure clinical utility and regulatory acceptance.
  • End Users: Academic institutes, diagnostic laboratories, hospitals, clinics, pharmaceutical and biotechnology companies seek robust, reproducible workflows with seamless integration into digital laboratory systems and health records, supporting both research and clinical adoption.
  • Service Models: Clinical testing services and research-oriented offerings, each requiring differentiated quality controls and operational strategies to align with user expectations and regulatory frameworks.
  • Components: Consumables such as kits and reagents, instruments, software, and bioinformatics solutions together define the operational flexibility and pricing structures available to end users.
  • Regional Coverage: Americas, Europe Middle East and Africa, and Asia-Pacific, each with distinct regulatory environments, partnership ecosystems, and levels of technology uptake influencing overall market development and competitive dynamics.

Key Takeaways for Decision-Makers

  • Clinical uptake of microbiome diagnostics is progressing, shifting from early research phases to implementations with demonstrated large-scale utility, emphasizing the need for strong validation pathways and consistent analytics.
  • Advanced bioinformatics and cloud-native data solutions provide differentiation, with integration into laboratory information management systems supporting broader deployment and robust quality assurance.
  • Regulatory and reimbursement requirements are evolving; market entry and sustained adoption are increasingly driven by clear clinical relevance, reproducibility, and evidence collected through collaborative partnerships.
  • Strategies tailored for distinct applications, technologies, and end users allow organizations to capture market growth while effectively managing regulatory and compliance complexities.
  • Collaboration among instrument manufacturers, laboratories, and academic centers accelerates clinical validation, supports technology integration, and helps tailor offerings to meet regional regulatory and patient population needs.

Tariff Impact: Supply Chain Resilience and Strategy

Changing United States tariff policies are creating uncertainty for microbiome diagnostics stakeholders, particularly around precision instruments and specialized consumables. In response, organizations are adopting strategies such as sourcing from diversified suppliers, securing long-term contracts, investing in regional manufacturing, and developing localized reagent production capabilities. These measures help mitigate potential disruptions, manage cost variability, and strengthen operational resilience. Commercial adaptations, including flexible leasing and strategic scenario planning, further enable laboratories and solution providers to continue essential operations despite procurement volatility.

Methodology & Data Sources

This analysis relies on primary interviews with stakeholders from clinical labs, academia, and industry, complemented by secondary reviews of technical literature, published regulatory guidelines, and manufacturer-enabled disclosures. Analytical rigor is supported by triangulation and expert validation to ensure alignment with real-world market conditions and trends.

Why This Report Matters

  • Senior leaders can benchmark technology, operational strategies, and tariff management approaches across global regions to identify opportunity and mitigate risk.
  • Actionable insights provided here support informed decisions for investment, procurement, and partnerships in fast-growing and high-impact clinical areas.
  • Comprehensive segment analysis and detailed regional intelligence enable organizations to tailor strategies for sustainable and differentiated market expansion in the microbiome diagnostics space.

Conclusion

Ongoing innovation, adaptive operations, and systematic validation are driving deeper clinical integration of microbiome diagnostics. Organizations prioritizing technical and executional excellence will be well-positioned to meet changing healthcare needs and support sustainable market growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Microbiome Diagnostics Market, by Technology
8.1. Microarray
8.2. Next-Gen Sequencing
8.2.1. 16S Rrna Sequencing
8.2.2. Shotgun Metagenomics
8.2.3. Whole Genome Sequencing
8.3. Qpcr
8.3.1. Digital Pcr
8.3.2. Real-Time Pcr
9. Microbiome Diagnostics Market, by Sample Type
9.1. Blood
9.2. Fecal
9.3. Oral
9.4. Skin
9.5. Urine
10. Microbiome Diagnostics Market, by Indication
10.1. Dermatological Conditions
10.2. Gastrointestinal Disorders
10.3. Infectious Diseases
10.4. Metabolic Disorders
10.5. Oncology
11. Microbiome Diagnostics Market, by Service Type
11.1. Clinical Testing Services
11.2. Research Services
12. Microbiome Diagnostics Market, by Component
12.1. Consumables
12.1.1. Kits & Reagents
12.1.2. Sample Preparation
12.2. Instruments
12.3. Software & Bioinformatics
12.3.1. Cloud Platforms
12.3.2. Data Analysis Software
12.3.3. LIMS Integration
13. Microbiome Diagnostics Market, by Diagnostic Application
13.1. Disease Diagnosis
13.2. Drug Development
13.2.1. Biomarker Discovery
13.2.2. Clinical Trials Support
13.3. Personalized Nutrition
13.4. Risk Assessment
13.5. Therapeutic Monitoring
14. Microbiome Diagnostics Market, by End User
14.1. Academic Research Institutes
14.2. Diagnostic Laboratories
14.3. Hospitals & Clinics
14.4. Pharmaceutical & Biotechnology Companies
15. Microbiome Diagnostics Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Microbiome Diagnostics Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Microbiome Diagnostics Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Microbiome Diagnostics Market
19. China Microbiome Diagnostics Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. 4D Pharma PLC
20.6. Admera Health LLC
20.7. AOBiome Therapeutics
20.8. Atlas Biomed
20.9. BioGaia
20.10. BIOHM Health
20.11. BiomeSense Ltd
20.12. Bione Ventures Private Limited
20.13. CosmosID, Inc.
20.14. DayTwo, Inc.
20.15. Diversigen, Inc.
20.16. DNA Genotek Inc. by OraSure Technologies Inc.
20.17. Enterome
20.18. Ferring Pharmaceuticals
20.19. Finch Therapeutics Group
20.20. Flightpath Biosciences, Inc.
20.21. Genetic Analysis AS
20.22. Genova Diagnostics, Inc.
20.23. International Flavors & Fragrances Inc
20.24. Microba Life Sciences
20.25. Microba Life Sciences Pty Ltd
20.26. Microbial Insights, LLC
20.27. Omnibiome, LLC
20.28. OptiBiotix Health PLC
20.29. Quantbiome, Inc.
20.30. Second Genome, Inc.
20.31. Seres Therapeutics
20.32. Synlogic, Inc.
20.33. Vedanta Biosciences, Inc.
20.34. Viome Life Sciences, Inc.
20.35. Viome, Inc.
20.36. YSOPIA Bioscience
List of Figures
FIGURE 1. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MICROBIOME DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SHOTGUN METAGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SHOTGUN METAGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY FECAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY FECAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY FECAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SKIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SKIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SKIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RESEARCH SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLOUD PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLOUD PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLOUD PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY LIMS INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY LIMS INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY LIMS INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY CLINICAL TRIALS SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PERSONALIZED NUTRITION, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PERSONALIZED NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PERSONALIZED NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 187. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 188. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 190. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 192. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 193. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 196. EUROPE MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 213. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 214. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 215. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 216. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 217. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 218. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 219. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 220. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 222. AFRICA MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 237. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 240. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 241. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 242. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 243. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 244. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 245. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 246. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 247. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 249. ASEAN MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 252. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 253. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 254. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 255. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 256. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 257. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 258. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 259. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 260. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 262. GCC MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 278. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 279. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 280. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 281. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 282. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 283. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 284. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 285. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 286. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 288. BRICS MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 290. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 291. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 292. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 293. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 294. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 295. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 296. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 297. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 298. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 299. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 301. G7 MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 302. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 303. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 304. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 305. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 306. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 307. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 308. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 309. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 310. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 311. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY SOFTWARE & BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 312. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATION, 2018-2032 (USD MILLION)
TABLE 313. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 314. NATO MICROBIOME DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 315. GLOBAL MICROBIOME DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 316. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 317. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 318. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY NEXT-GEN SEQUENCING, 2018-2032 (USD MILLION)
TABLE 319. UNITED STATES MICROBIOME DIAGNOSTICS MARKET SIZE, BY QPCR, 2018-2032 (USD MILLION)
TABLE 320.

Companies Mentioned

The key companies profiled in this Microbiome Diagnostics market report include:
  • 4D Pharma PLC
  • Admera Health LLC
  • AOBiome Therapeutics
  • Atlas Biomed
  • BioGaia
  • BIOHM Health
  • BiomeSense Ltd
  • Bione Ventures Private Limited
  • CosmosID, Inc.
  • DayTwo, Inc.
  • Diversigen, Inc.
  • DNA Genotek Inc. by OraSure Technologies Inc.
  • Enterome
  • Ferring Pharmaceuticals
  • Finch Therapeutics Group
  • Flightpath Biosciences, Inc.
  • Genetic Analysis AS
  • Genova Diagnostics, Inc.
  • International Flavors & Fragrances Inc
  • Microba Life Sciences
  • Microba Life Sciences Pty Ltd
  • Microbial Insights, LLC
  • Omnibiome, LLC
  • OptiBiotix Health PLC
  • Quantbiome, Inc.
  • Second Genome, Inc.
  • Seres Therapeutics
  • Synlogic, Inc.
  • Vedanta Biosciences, Inc.
  • Viome Life Sciences, Inc.
  • Viome, Inc.
  • YSOPIA Bioscience

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.41 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.63 Billion
Compound Annual Growth Rate21.7%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

Human Microbiome Market - Global Forecast 2026-2032 - Product Image

Human Microbiome Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Cancer Microbiome Sequencing Market - Global Forecast 2026-2032 - Product Image

Cancer Microbiome Sequencing Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Microbiome Sequencing Services - Global Strategic Business Report - Product Image

Microbiome Sequencing Services - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Microbiome Diagnostics - Global Strategic Business Report - Product Image

Microbiome Diagnostics - Global Strategic Business Report

  • Report
  • 569 Pages
  • Global
From
Human Microbiome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Human Microbiome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 116 Pages
  • Global
From

About the Microbiome Diagnostics Market

Within the field of biotechnology, the microbiome diagnostics market encompasses a range of technologies and products aimed at analyzing and understanding the complex communities of microorganisms, particularly bacteria and fungi, that inhabit various environments, including the human body. These diagnostics are crucial for advancing the comprehension of the human microbiome and its impact on health and disease. This market leverages advancements in genomics, proteomics, and bioinformatics to identify microbial compositions in different biological samples. The applications of microbiome diagnostics are broad, ranging from identifying dysbiosis associated with disease states to predicting the response to therapeutics and personalizing treatment plans. Microbiome diagnostics play a pivotal role in preventive medicine, nutrition, and the development of targeted therapies by providing insights into the correlation between microbial flora and patient outcomes. The approach has been especially fruitful in the areas of gastrointestinal and metabolic diseases, where the gut microbiome is known to have a major influence. Additionally, the research in this field is rapidly expanding, with discoveries regularly enhancing the potential of microbiome-based diagnostics and therapeutics. Several companies have established themselves in the microbiome diagnostics market, contributing to its growth and innovation. Notable among these are uBiome (now rebranded as BiomeSense), which specializes in microbial genomics for health, disease, and lifestyle; Second Genome, a company that has developed a platform for microbiome science to influence disease treatment and prevention; and CosmosID, which offers microbial genomics solutions for infectious disease diagnostics and microbiome analysis Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.